MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 151 filers reported holding MACROGENICS INC in Q2 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,699,502 | -12.9% | 364,700 | 0.0% | 0.02% | -13.0% |
| Q2 2023 | $1,951,145 | +109.4% | 364,700 | +35.4% | 0.02% | +76.9% |
| Q3 2022 | $932,000 | +17.4% | 269,272 | 0.0% | 0.01% | +8.3% |
| Q2 2022 | $794,000 | -66.5% | 269,272 | 0.0% | 0.01% | -69.2% |
| Q1 2022 | $2,372,000 | -45.1% | 269,272 | 0.0% | 0.04% | -37.1% |
| Q4 2021 | $4,322,000 | -75.0% | 269,272 | -67.4% | 0.06% | -78.0% |
| Q3 2021 | $17,290,000 | +162.1% | 825,669 | +236.2% | 0.28% | +129.3% |
| Q2 2021 | $6,597,000 | – | 245,596 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,215,675 | $6,503,861 | 2.01% |
| Bellevue Group AG | 9,609,913 | $51,413,035 | 0.73% |
| Frazier Life Sciences Management, L.P. | 1,803,204 | $9,647,141 | 0.58% |
| ARMISTICE CAPITAL, LLC | 5,600,000 | $29,960,000 | 0.43% |
| Delphia (USA) Inc. | 37,988 | $203,236 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 352,497 | $1,885,859 | 0.31% |
| Corton Capital Inc. | 73,678 | $394,177 | 0.18% |
| Rock Springs Capital Management LP | 1,123,096 | $6,008,564 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 129,158 | $691 | 0.07% |
| PINNACLE ASSOCIATES LTD | 709,903 | $3,797,981 | 0.07% |